活化血小板，慢性肾脏疾病和心血管并发症的助推器。

IF 3.2 4区医学 Q1 UROLOGY & NEPHROLOGY

Kidney Diseases Pub Date : 2022-06-03 eCollection Date: 2022-07-01 DOI:10.1159/000525090

Shuiqin Gong, Chenyu Wang, Jiachuan Xiong, Jinghong Zhao, Ke Yang

{"title":"活化血小板，慢性肾脏疾病和心血管并发症的助推器。","authors":"Shuiqin Gong, Chenyu Wang, Jiachuan Xiong, Jinghong Zhao, Ke Yang","doi":"10.1159/000525090","DOIUrl":null,"url":null,"abstract":"Background Chronic kidney disease (CKD) has become a global public health problem nowadays. As cardiovascular diseases (CVDs) are the primary cause of death in advanced CKD patients, much attention has been paid to resolving their cardiovascular complications. However, managing CKD and cardiovascular complications is still a big challenge for nephrologists, as satisfactory treatments are still lacking. Platelets, the second most abundant cells in the blood, are the major participants of hemostasis, thrombosis, and wound healing. In recent years, platelets have been reported in various physiological and pathological processes, including CKD and CKD-related CVDs.","PeriodicalId":17830,"journal":{"name":"Kidney Diseases","volume":"8 4","pages":"297-307"},"PeriodicalIF":3.2000,"publicationDate":"2022-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3b/4f/kdd-0008-0297.PMC9386414.pdf","citationCount":"3","resultStr":"{\"title\":\"Activated Platelets, the Booster of Chronic Kidney Disease and Cardiovascular Complications.\",\"authors\":\"Shuiqin Gong, Chenyu Wang, Jiachuan Xiong, Jinghong Zhao, Ke Yang\",\"doi\":\"10.1159/000525090\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background Chronic kidney disease (CKD) has become a global public health problem nowadays. As cardiovascular diseases (CVDs) are the primary cause of death in advanced CKD patients, much attention has been paid to resolving their cardiovascular complications. However, managing CKD and cardiovascular complications is still a big challenge for nephrologists, as satisfactory treatments are still lacking. Platelets, the second most abundant cells in the blood, are the major participants of hemostasis, thrombosis, and wound healing. In recent years, platelets have been reported in various physiological and pathological processes, including CKD and CKD-related CVDs.\",\"PeriodicalId\":17830,\"journal\":{\"name\":\"Kidney Diseases\",\"volume\":\"8 4\",\"pages\":\"297-307\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2022-06-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3b/4f/kdd-0008-0297.PMC9386414.pdf\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kidney Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000525090\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/7/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000525090","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/7/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}

引用次数: 3

摘要

慢性肾脏疾病(CKD)已成为当今全球性的公共卫生问题。由于心血管疾病是晚期CKD患者死亡的主要原因，心血管并发症的治疗一直受到人们的重视。然而，管理CKD和心血管并发症对肾病学家来说仍然是一个很大的挑战，因为仍然缺乏令人满意的治疗方法。血小板是血液中第二丰富的细胞，是止血、血栓形成和伤口愈合的主要参与者。近年来，血小板在各种生理和病理过程中被报道，包括CKD和CKD相关的cvd。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Activated Platelets, the Booster of Chronic Kidney Disease and Cardiovascular Complications.

查看原文本刊更多论文

Activated Platelets, the Booster of Chronic Kidney Disease and Cardiovascular Complications.

Background Chronic kidney disease (CKD) has become a global public health problem nowadays. As cardiovascular diseases (CVDs) are the primary cause of death in advanced CKD patients, much attention has been paid to resolving their cardiovascular complications. However, managing CKD and cardiovascular complications is still a big challenge for nephrologists, as satisfactory treatments are still lacking. Platelets, the second most abundant cells in the blood, are the major participants of hemostasis, thrombosis, and wound healing. In recent years, platelets have been reported in various physiological and pathological processes, including CKD and CKD-related CVDs.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Kidney Diseases UROLOGY & NEPHROLOGY-

CiteScore

6.00

自引率

2.70%

发文量

审稿时长

27 weeks

期刊介绍： ''Kidney Diseases'' aims to provide a platform for Asian and Western research to further and support communication and exchange of knowledge. Review articles cover the most recent clinical and basic science relevant to the entire field of nephrological disorders, including glomerular diseases, acute and chronic kidney injury, tubulo-interstitial disease, hypertension and metabolism-related disorders, end-stage renal disease, and genetic kidney disease. Special articles are prepared by two authors, one from East and one from West, which compare genetics, epidemiology, diagnosis methods, and treatment options of a disease.